Identification of Opioid Ligands Possessing Mixed ... - ACS Publications

Apr 2, 2004 - ... Possessing Mixed μ Agonist/δ Antagonist Activity among Pyridomorphinans Derived from Naloxone, Oxymorphone, and Hydromorphone...
0 downloads 0 Views 9KB Size
2716

J. Med. Chem. 2004, 47, 2716

Additions and Corrections 2004, Volume 47 Subramaniam Ananthan,* Naveen K. Khare, Surendra K. Saini, Lainne E. Seitz, Jeffrey L. Bartlett, Peg Davis, Christina M. Dersch, Frank Porreca, Richard B. Rothman, and Edward J. Bilsky: Identification of Opioid Ligands Possessing Mixed µ Agonist/δ Antagonist Activity among Pyridomorphinans Derived from Naloxone, Oxymorphone, and Hydromorphone. Page 1400. “Hydromorphone” in the title was misspelled. The correct title is shown above. JM0400597 10.1021/jm0400597 Published on Web 04/02/2004

Bruce E. Maryanoff: Inhibitors of Serine Proteases as Potential Therapeutic Agents: The Road from Thrombin to Tryptase to Cathepsin G. Page 783. The caption to Figure 16 is missing the descriptive labels for each curve. The correct caption is the following: Figure 16. Response of 17f in the allergen-sensitized sheep model of asthma (filled squares) vs control (filled circles).55 Protocol: 0.1 mg/kg of 17f was administered by aerosol twice daily for 3 days and then at 0.5 h before day 4, when the allergen Ascaris suum was delivered. JM040064A 10.1021/jm040064a Published on Web 04/03/2004